title: Upregulation of persistent sodium conductances in familial ALS.
abstract: BACKGROUND
  Upregulation of persistent Na(+) conductances has been linked to axonal degeneration in sporadic amyotrophic lateral sclerosis (ALS) and has also been reported in the transgenic superoxide dismutase-1 (SOD-1) mouse model. The mechanisms of ectopic activity (fasciculations and cramp) and axonal degeneration still require clarification in familial ALS (FALS) in humans, and specifically whether there are any differences to the processes identified in sporadic patients. Consequently, novel threshold tracking techniques were used to assess whether upregulation of persistent Na(+) conductances was a feature linked to axonal degeneration in FALS.
  
  
  METHODS
  Axonal excitability studies were undertaken in six FALS patients, 13 asymptomatic SOD-1 mutation carriers and 45 sporadic ALS (SALS) patients.
  
  
  RESULTS
  Compound muscle action potential amplitude was significantly reduced in FALS (6.3+/-1.3 mV) and SALS (6.0+/-0.4 mV) compared with controls (10.0+/-0.4 mV, p<0.05). The mean strength duration time constant (tau(SD)) was significantly increased in FALS (0.55+/-0.10 ms, p<0.05) and SALS (0.52+/-0.02 ms, p<0.01) compared with controls (0.41+/-0.02). There were no differences in tau(SD) between asymptomatic SOD-1 mutation carriers and controls. The increase in tau(SD) correlated with the CMAP amplitude (r=-0.4) and neurophysiological index (r=-0.4). In separate studies that assessed cortical processes, short interval intracortical inhibition (SICI) was significantly reduced (FALS, -2.7+/-1.3%; controls 13.7+/-1.3%, p<0.0001) and intracortical facilitation increased (FALS, -5.0+/-2.2%; controls -0.4+/-1.1%, p<0.05) in FALS. The reduction in SICI correlated with tau(SD) (r=-0.8).
  
  
  CONCLUSIONS
  Taken together, these studies suggest that persistent Na(+) conductances are upregulated in FALS and that this upregulation is intrinsically associated with axonal degeneration.
authors.affiliation: Department of Neurology, Westmead Hospital and Western Clinical School, University of Sydney, Sydney, Australia.
authors.forename: Steve
authors.initials: S
authors.lastname: Vucic
authors.forename: Matthew C
authors.initials: MC
authors.lastname: Kiernan
mesh_terms: D000328:Adult; D000690:Amyotrophic Lateral Sclerosis / Q000235:genetics* / Q000378:metabolism*; D001369:Axons / Q000378:metabolism / Q000473:pathology; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009410:Nerve Degeneration / Q000378:metabolism / Q000473:pathology; D015222:Sodium Channels / Q000378:metabolism*; D015854:Up-Regulation / Q000235:genetics*; D055815:Young Adult
chemical_list: D015222:Sodium Channels